According to the researchers, the findings indicated that the two drugs may have neuroprotective effects for people without diabetes and may help slow the rate of cognitive decline in Alzheimer's ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Unfortunately, rather than addressing the fundamental lifestyle factors that contribute to Type 2 diabetes, patients and providers have become increasingly reliant on medications that slow the ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

Weight-reducing diabetes medications, specifically SGLT2 inhibitors and GLP-1 receptor agonists, may increase fall risk in type 2 diabetes patients due to potential muscle mass loss.

Researchers have launched a phase 1/2 clinical trial to see if osteoporosis medication can enhance beta cell health among people living with early type 1 diabetes. During the trial, scientists from ...

2025 — Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts ... Mar. 27, 2025 — A research team has ...

It’s unclear why this happens. Nerve damage, medication, and other factors may play a role. About 10% of people with diabetes experience diarrhea. Those with diabetes are more likely to have ...

Lifestyle changes may help manage diabetes for some people. If the condition progresses, you‘re more likely to need medications that keep your blood sugar levels within the standard range.

We recommend that clinicians screen all women with diabetes or prediabetes for desire, arousal, and orgasm difficulties and signs and symptoms of genitourinary syndrome of menopause. Treatment of ...

Notably, Hsu and colleagues reported that the increased risk for NAION was found only in women with diabetes who received semaglutide vs. those who received a non-GLP-1 RA medication.